7 results match your criteria: "King's College Hospital and King's Health Partners[Affiliation]"

Clinical implications of intratumor heterogeneity: challenges and opportunities.

J Mol Med (Berl)

February 2020

Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.

In this review, we highlight the role of intratumoral heterogeneity, focusing on the clinical and biological ramifications this phenomenon poses. Intratumoral heterogeneity arises through complex genetic, epigenetic, and protein modifications that drive phenotypic selection in response to environmental pressures. Functionally, heterogeneity provides tumors with significant adaptability.

View Article and Find Full Text PDF

Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries.

Circulation

January 2018

King's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.)

Background: Extracellular matrix (ECM) remodeling contributes to in-stent restenosis and thrombosis. Despite its important clinical implications, little is known about ECM changes post-stent implantation.

Methods: Bare-metal and drug-eluting stents were implanted in pig coronary arteries with an overstretch under optical coherence tomography guidance.

View Article and Find Full Text PDF
Article Synopsis
  • The GOLIATH study is a 2-year clinical trial comparing two treatments for benign prostatic obstruction: transurethral resection of the prostate (TURP) and photoselective vaporization using the GreenLight XPS laser, with a focus on maintaining treatment effects seen at the 6-month mark over two years.
  • The trial involved 281 patients across 29 centers in Europe and measured outcomes like the International Prostate Symptom Score and other health indicators, aiming to prove that GL-XPS is not inferior to TURP.
  • Results showed that GL-XPS maintained similar effectiveness and safety compared to TURP over the two years, with fewer complications and comparable reductions in prostate size and specific antigen levels, though some
View Article and Find Full Text PDF

Purpose: We present the 1-year results of the GOLIATH prospective randomized controlled trial comparing transurethral resection of the prostate to GreenLight XPS for the treatment of men with nonneurogenic lower urinary tract symptoms due to prostate enlargement. The updated results at 1 year show that transurethral resection of the prostate and GreenLight XPS remain equivalent, and confirm the therapeutic durability of both procedures. We also report 1-year followup data from several functional questionnaires (OABq-SF, ICIQ-SF and IIEF-5) and objective assessments.

View Article and Find Full Text PDF

Background: The comparative outcome with GreenLight (GL) photoselective vaporisation of the prostate and transurethral resection of the prostate (TURP) in men with lower urinary tract symptoms due to benign prostatic obstruction (BPO) has been questioned.

Objective: The primary objective of the GOLIATH study was to evaluate the noninferiority of 180-W GL XPS (XPS) to TURP for International Prostate Symptom Score (IPSS) and maximum flow rate (Qmax) at 6 mo and the proportion of patients who were complication free.

Design, Setting, And Participants: Prospective randomised controlled trial at 29 centres in 9 European countries involving 281 patients with BPO.

View Article and Find Full Text PDF

Objective: To investigate the prognostic value of baseline and temporal changes in red cell distribution width (RDW) in patients undergoing transcatheter aortic valve implantation (TAVI).

Design: Single-centre retrospective observational study.

Setting: Tertiary cardiac centre.

View Article and Find Full Text PDF

Tumor heterogeneity is a confusing finding in the assessment of neoplasms, potentially resulting in inaccurate diagnostic, prognostic and predictive tests. This tumor heterogeneity is not always a random and unpredictable phenomenon, whose knowledge helps designing better tests. The biologic reasons for this intratumoral heterogeneity would then be important to understand both the natural history of neoplasms and the selection of test samples for reliable analysis.

View Article and Find Full Text PDF